Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Porfiromycin as Adjuvant to Radiation in Head and Neck Cancer
NCT00003328Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of porfiromycin in head and neck cancer (HNC), sponsored by Boehringer Ingelheim. Started Dec 1997; status: completed.
02
Drugs
porfiromycin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00003328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003328.